Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Immunology|May 1, 1996
Mechanisms of action of intravenous immune globulin in immune-mediated diseasesL Mouthon, S V Kaveri, S H Spalter, et al.
Arthritis Care & Research|August 20, 2010
Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patientsI Marie, J-F Menard, P Y Hatron, et al.
Annals of the Rheumatic Diseases|May 28, 2008
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patientsC Charlier, C Henegar, O Launay, et al.
The International Journal of Neuroscience|July 15, 2016
High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and toleranceE Hachulla, O Benveniste, M Hamidou, et al.
The British Journal of Dermatology|August 6, 2021
Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scaleJ Sibeoni, B Dunogué, A Dupont, et al.
Scandinavian Journal of Immunology|March 1, 1997
Instability of natural antibody repertoires in systemic lupus erythematosus patients, revealed by multiparametric analysis of serum antibody reactivitiesC Ferreira, L Mouthon, A Nobrega, et al.
Ocular Immunology and Inflammation|April 2, 2008
Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype dataS Abad, D Monnet, S Caillat-Zucman, et al.
Annales De Dermatologie Et De Venereologie|August 7, 2016
[Pansclerotic morphea with a rapidly fatal outcome in an 11-year-old girl]J Hardy, C Audouin-Pajot, A Abid, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patientsJ Marmursztejn, O Vignaux, P Cohen, et al.
Annals of the Rheumatic Diseases|March 17, 2007
Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosisA Servettaz, P Guilpain, C Goulvestre, et al.
Pageof 15